Sort
30,917 grants matching “tumor microenvironment”
Tumor microenvironment: Impact on T cell tumor-targeting, activation and survival
$490,230Ronald G Blasberg · Sloan-Kettering Inst Can Research · R01 · FY2013 · CA
Investigating molecular and cellular mechanisms of SCLC development to identify novel therapeutic strategies
$490,211Julien Sage · Stanford University · R35 · FY2019 · CA
FOXA1 regulates cytokine signaling and immune landscape in prostate cancer through ARID1A
$490,082Jindan Yu · Emory University · R01 · FY2024 · CA
Novel Protein Engineered Drug Conjugates Targeting Phosphatidylserine for the Treatment of Breast Cancer
$490,013Kevin G Pinney · Baylor University · R01 · FY2020 · CA
Role of immune regulation in colorectal cancer chemotherapeutic response
$489,979Jun Lu · Yale University · R01 · FY2025 · CA
Co-targeting the HER3 oncogenic signaling circuitry and PD-1 as a novel multimodal precision immunotherapy for HNSCC
$489,974J. Silvio Gutkind · University Of California, San Diego · R01 · FY2022 · CA
Co-targeting the HER3 oncogenic signaling circuitry and PD-1 as a novel multimodal precision immunotherapy for HNSCC
$489,974J. Silvio Gutkind · University Of California, San Diego · R01 · FY2023 · CA
Targeting AVIL in Glioblastoma
$489,873Hui Li · University Of Virginia · R01 · FY2020 · CA
Tumor-specific CD8+ Tc9 cells activate host CD4+ T cells to control antigen-lost tumors
$489,857Qing Yi · Methodist Hospital Research Institute · R01 · FY2024 · CA
Tumor-specific CD8+ Tc9 cells activate host CD4+ T cells to control antigen-lost tumors
$489,857Qing Yi · Methodist Hospital Research Institute · R01 · FY2025 · CA
Stimuli-responsive mucin1-specific nanoparticles for efficacious combinatorial chemotherapy of pancreatic ductal adenocarcinoma
$489,818Juan Luis Vivero-Escoto · University Of North Carolina Charlotte · R01 · FY2025 · CA
Regulation of memory T cell differentiation and long-term maintenance
$489,800Ananda W Goldrath · University Of Florida · P01 · FY2022 · AI
Genomics and Computational Biology Shared Resource
$489,709Kelly A Frazer · University Of California, San Diego · P30 · FY2020 · CA
Racial differences in Immunogenetic Tumorigenesis of Head and Neck Squamous Cell Carcinoma
$489,635David Sidransky · Johns Hopkins University · R01 · FY2022 · CA
Image-guided radiation-induced permeability (IGRIP) for IGDD
$489,602Stephen J. Kron · University Of Chicago · R01 · FY2018 · CA
Project 2:Nanoparticle-based Immune Modulators in Cancer Therapy & Vaccines
$489,587Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · U54 · FY2017 · CA
Discrete Frequency Infrared Spectroscopic Imaging for Breast Histopathology
$489,578Rohit Bhargava · University Of Illinois At Urbana-Champaign · R01 · FY2022 · EB
Mechanisms of Variant ER-alpha Function in Breast Cancer
$489,550Amy Fowler · University Of Wisconsin-Madison · R01 · FY2025 · CA
Mechanisms of treatment failure in chimeric antigen receptor T cell therapy
$489,534Brian Till · Fred Hutchinson Cancer Center · R01 · FY2022 · CA
Mechanisms of treatment failure in chimeric antigen receptor T cell therapy
$489,533Brian Till · Fred Hutchinson Cancer Center · R01 · FY2023 · CA
Cancer Heterogeneity, Immunity, and Microenvironment (CHIME) Training Program
$489,363Susan M Kaech · Salk Institute For Biological Studies · T32 · FY2024 · CA
CD19 Directed CAR Therapy
$489,347Carl H. June · University Of Pennsylvania · R01 · FY2014 · CA
Lymphoid Experimental Therapeutics Platform to Study Cooperative Signaling inHuman Lymphomas
$489,269Ankur Singh · Georgia Institute Of Technology · R01 · FY2020 · CA
Genetic requirements of Helicobacter pylori infection
$489,160Nina Reda Salama · Fred Hutchinson Cancer Center · R01 · FY2025 · AI
Understanding the influence of bone-metastatic prostate cancer and mesenchymal stromal cells on γδ T cells, in the bone microenvironment.
$489,115Daniel Abate-Daga · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA